NCT06959082 2026-03-11Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck CancerVSPharmTech Co.,Ltd.Phase 2 Recruiting30 enrolled
NCT06305910 2024-03-12CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young AdultsOX2 TherapeuticsPhase 1 Recruiting24 enrolled